Health Care & Life Sciences » Pharmaceuticals | Purapharm Corp. Ltd.

Purapharm Corp. Ltd. | Balance Sheet

Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
49
67
238
220
96
114
Total Accounts Receivable
114
118
164
239
243
293
Inventories
65
90
108
167
301
259
Other Current Assets
13
30
31
33
53
66
Total Current Assets
240
306
541
659
692
732
Net Property, Plant & Equipment
81
78
94
117
316
323
Total Investments and Advances
10
11
13
14
22
11
Intangible Assets
5
7
9
26
191
192
Other Assets
7
14
33
32
57
59
Total Assets
348
420
697
860
1,294
1,333
ST Debt & Current Portion LT Debt
183
183
125
261
494
Accounts Payable
30
45
38
74
112
Income Tax Payable
2
4
5
7
5
Other Current Liabilities
53
52
58
60
73
Total Current Liabilities
268
283
226
403
684
Long-Term Debt
5
-
-
-
54
Deferred Taxes
5
5
7
11
14
Total Liabilities
273
283
226
404
741
Common Equity (Total)
73
136
470
455
549
Total Shareholders' Equity
73
136
470
455
549
Total Equity
73
136
470
455
549
Liabilities & Shareholders' Equity
348
420
697
860
1,294
Accumulated Minority Interest
-
-
-
-
-
Non-Equity Reserves
2
2
1
1
4

About Purapharm Corp.

View Profile
Address
Suite 4002, Jardine House
Hong Kong
Hong Kong
Employees -
Website http://www.purapharm.com
Updated 07/08/2019
PuraPharm Corp. Ltd. operates as an investment holding company. It engages in the research and development, production and sale of concentrated Chinese medicine granule (CCMG) products and Chinese healthcare products, as well as rendering of Chinese medical diagnostic services. The company operates through the following segments: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, and Clinics.